2019
DOI: 10.1016/j.jpeds.2019.01.042
|View full text |Cite
|
Sign up to set email alerts
|

Promoting Cardiovascular Health in Early Childhood and Transitions in Childhood through Adolescence: A Workshop Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
12
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 107 publications
(108 reference statements)
1
12
0
Order By: Relevance
“…However, this risk can be reversed if individuals attain a low level of adiposity by adolescence or avoid becoming obese. Identifying children at high risk of developing obesity would allow preventive and intervention efforts to be initiated at an early life-stage ( 101 , 102 ).…”
Section: Early Prediction Of Future Cardiometabolic Riskmentioning
confidence: 99%
“…However, this risk can be reversed if individuals attain a low level of adiposity by adolescence or avoid becoming obese. Identifying children at high risk of developing obesity would allow preventive and intervention efforts to be initiated at an early life-stage ( 101 , 102 ).…”
Section: Early Prediction Of Future Cardiometabolic Riskmentioning
confidence: 99%
“…This study demonstrated the typical trajectory curves of RV function and established reference values of the TAPSE Numerous studies have shown that cardiovascular disease (CVD) that ultimately results in disability and premature death outcomes begins in childhood and progresses into adulthood [1][2][3][4][5]. Among childhood CVD risk factors, BMI is the strongest predictor of adult metabolic syndrome [6], defined as a cluster of abnormalities, including central obesity, increased blood pressure, lipid abnormalities, and impaired glucose tolerance, all are well-documented risk factors for CVD.…”
mentioning
confidence: 60%
“…1 This allows us to draw attention to our reported cohort of 38 children with a liver disease of indeterminate etiology, in most cases presenting with acute hepatitis (n = 14) or with PALF (n = 15). 2 This condition was tentatively called "seronegative autoimmune hepatitis" because of the liver histology, the prompt response to immunosuppressive therapy used in typical autoimmune hepatitis 3,4 (prednisone alone or with azathioprine or cyclosporine), and the lack of specific autoantibodies. These features, combined with the lack of evidence of known causes of acute and chronic liver diseases, suggested immune dysregulation and activation.…”
Section: Immunosuppressive Therapy For Indeterminate Acute Hepatitis mentioning
confidence: 99%